{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:40:20Z","timestamp":1757619620612,"version":"3.44.0"},"reference-count":34,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1994,9]]},"DOI":"10.1136\/gut.35.9.1155","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"1155-1158","source":"Crossref","is-referenced-by-count":13,"title":["New salicylates as maintenance treatment in ulcerative colitis."],"prefix":"10.1136","volume":"35","author":[{"given":"G","family":"J\u00e4rnerot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1994,9,1]]},"reference":[{"key":"ref_1","first-page":"892","article-title":"An experiment to determine the active therapeutic moiety of sulphasalazine","volume":"i:","author":"AK, Azad Khan; J, Piris; SC, Truelove","year":"1977","unstructured":"Azad Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977; i: 892-5.","journal-title":"Lancet"},{"key":"ref_2","first-page":"270","article-title":"Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas","volume":"ii:","author":"Campieri, M.; Lanfranchi, G.A.; Bazzochi, G.","year":"1981","unstructured":"Campieri M, Lanfranchi GA, Bazzochi G, et al. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet 1981; ii: 270-1.","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/BF01296159","article-title":"Danish 5-ASA group. Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis: a randomized double-blind multicenter trial","volume":"32","year":"1987","unstructured":"Danish 5-ASA group. Topical 5-aminosalicylic acid versus prednisolone in ulcerative proctosigmoiditis: a randomized double-blind multicenter trial. Dig Dis Sci 1987; 32: 598-602.","journal-title":"Dig Dis Sci"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/0003-4819-118-7-199304010-00009","article-title":"Sulfasalazine revisited: a metaanalysis of 5-aminosalicylic acid in the treatment of ulcerative colitis","volume":"118","author":"Sutherland, L.R.; May, G.R.; Shaffer, E.A.","year":"1993","unstructured":"Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: a metaanalysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 540-9.","journal-title":"Ann Intern Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0016-5085(86)90882-6","article-title":"Azodisal sodium in the treatment of ulcerative colitis: a study of tolerance and relapse-prevention properties","volume":"90","author":"H, Sandberg Gertzen; G, Jarnerot; W, Kraaz","year":"1986","unstructured":"Sandberg Gertzen H, Jarnerot G, Kraaz W. Azodisal sodium in the treatment of ulcerative colitis: a study of tolerance and relapse-prevention properties. Gastroenterology 1986; 90: 1024-30.","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/BF01296107","article-title":"Olsalazine in maintenance of clinical remission in patients with ulcerative colitis","volume":"38","author":"Wright, J.P.; O'Keefe, E.A.; Cuming, L.; Jaskiewicz, K.","year":"1993","unstructured":"Wright JP, O'Keefe EA, Cuming L, Jaskiewicz K. Olsalazine in maintenance of clinical remission in patients with ulcerative colitis. Dig Dis Sci 1993; 38: 1837-42.","journal-title":"Dig Dis Sci"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bmj.285.6347.1012","article-title":"Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid","volume":"285","author":"Dew, M.J.; Hughes, P.; Harries, A.D.; Williams, G.; Evans, B.K.; Rhodes, J.","year":"1982","unstructured":"Dew MJ, Hughes P, Harries AD, Williams G, Evans BK, Rhodes J. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. BMJ 1982; 285: 1012.","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0016-5085(88)90677-4","article-title":"Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis","volume":"94","author":"Riley, S.A.; Mani, V.; Groodman, M.J.; Herd, M.E.; Dutt, S.; Turnberg, L.A.","year":"1988","unstructured":"Riley SA, Mani, V, Groodman MJ, Herd ME, Dutt S, Turnberg LA. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 1988; 94: 1383-9.","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.287.6384.23","article-title":"Maintenance of remission in ulcerative colitis with 5-aminosalicylic acid in high doses by mouth","volume":"287","author":"Dew, M.J.; Harries, A.D.; Evans, N.; Evans, B.K.; Rhodes, J.","year":"1983","unstructured":"Dew MJ, Harries AD, Evans N, Evans BK, Rhodes J. Maintenance of remission in ulcerative colitis with 5-aminosalicylic acid in high doses by mouth. BMJ 1983; 287: 23-4.","journal-title":"BMJ"},{"key":"ref_10","first-page":"1449","article-title":"Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance","volume-title":"ulcerative colitis. Gastroenterology 1988; 95","author":"Mulder, C.J.J.; Tytgat, G.N.J.; Weterman, I.T.; Dekker, W.; Blok, P.; Schrijver, M.","unstructured":"Mulder CJJ, Tytgat GNJ, Weterman IT, Dekker W, Blok P, Schrijver M, et al. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology 1988; 95: 1449-53."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2036.1989.tb00204.x","article-title":"behalf of an international study group). Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis","volume":"3","author":"(on, Rutgeerts P","year":"1989","unstructured":"Rutgeerts P (on behalf of an international study group). Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. Alimentary Pharmacology and Therapy 1989; 3: 183-91.","journal-title":"Alimentary Pharmacology and Therapy"},{"key":"ref_12","first-page":"47","article-title":"Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission","volume":"26","author":"Eliakim, R.; Ligumsky, M.; Wengrover, D.; Rachmilewitz, D.","year":"1990","unstructured":"Eliakim R, Ligumsky M, Wengrover D, Rachmilewitz D. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission. IsrJ Med Sci 1990; 26: 47-9.","journal-title":"IsrJ Med Sci"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/gut.29.6.835","article-title":"A controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis","volume":"29","author":"Ireland, A.; Mason, C.H.; Jewell, D.P.","year":"1988","unstructured":"Ireland A, Mason CH, Jewell DP. A controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis. Gut 1988; 29: 835-7.","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/gut.33.2.252","article-title":"PJ and the Danish olsalazine study group. Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis","volume":"33","author":"Kiilerich, S.; Ladefoged, K.; Rannem, T.; Ranl0v","year":"1992","unstructured":"Kiilerich S, Ladefoged K, Rannem T, Ranl0v PJ and the Danish olsalazine study group. Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. Gut 1992; 33: 252-5.","journal-title":"Gut"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2036.1988.tb00693.x","article-title":"Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine","volume":"2","author":"McIntyre, P.B.; Rodrigues, C.A.; Lennard-Jones, J.E.; Barrison, I.G.; Walker, J.G.; Baron, J.G.","year":"1988","unstructured":"McIntyre PB, Rodrigues CA, Lennard-Jones JE, Barrison IG, Walker JG, Baron JG, et al. Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double-blind comparison with sulphasalazine. Alimentary Pharmacology and Therapy 1988; 2: 237-43.","journal-title":"Alimentary Pharmacology and Therapy"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0140-6736(92)91601-4","article-title":"et aL Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis","volume":"339","author":"Courtney, M.G.; Nunes, D.P.; Bergin, C.F.; O'Driscoll, M.; Trimble, V.; Keeling, P.W.N.","year":"1992","unstructured":"Courtney MG, Nunes DP, Bergin CF, O'Driscoll M, Trimble V, Keeling PWN, et aL Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet 1992; 339: 1279-81.","journal-title":"Lancet"},{"key":"ref_17","first-page":"232","article-title":"Optimum dose of sulphasalazine for maintenance treatment of ulcerative colitis Gut","volume":"21","author":"AK, Azad Khan; D, Howes; J, Piris; SC, Truelove","year":"1980","unstructured":"Azad Khan AK, Howes D, Piris J, Truelove SC. Optimum dose of sulphasalazine for maintenance treatment of ulcerative colitis Gut 1980; 21: 232-40."},{"key":"ref_18","article-title":"The optimum dose of olsalazine for maintaining remission in ulcerative colitis","author":"Travis, S.P.L.; Tysk, C.; De Silva, H.J.; Sandberg Gertzen, H.; Jewell, D.P.; Jarnerot, G.","year":"1994","unstructured":"Travis SPL, Tysk C, De Silva HJ, Sandberg Gertzen H, Jewell DP, Jarnerot G. The optimum dose of olsalazine for maintaining remission in ulcerative colitis. Gut 1994; 34 (in press).","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2036.1992.tb00561.x","article-title":"Improved maintenance of remission in ulcerative colitis by balsalazide 4 g\/day compared with 2 g\/day","volume":"6","author":"Giaffer, M.H.; Holdsworth, C.D.; Lennard-Jones, J.E.; Rodrigues, C.A.; McIntyre, P.B.; Manjunatha, S.","year":"1992","unstructured":"Giaffer MH, Holdsworth CD, Lennard-Jones JE, Rodrigues CA, McIntyre PB, Manjunatha S, et al. Improved maintenance of remission in ulcerative colitis by balsalazide 4 g\/day compared with 2 g\/day. Alimentary Pharmacology and Therapy 1992; 6: 479-85.","journal-title":"Alimentary Pharmacology and Therapy"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2036.1992.tb00578.x","article-title":"Comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months","volume":"6","author":"Green, J.R.B.; Swan, C.H.J.; Rowlinson, A.; Gibson, J.A.; Brown, P.; Kerr, G.D.","year":"1992","unstructured":"Green JRB, Swan CHJ, Rowlinson A, Gibson JA, Brown P, Kerr GD, et al. Comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months. Alimentary Pharmacology and Therapy 1992; 6: 647-52.","journal-title":"Alimentary Pharmacology and Therapy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/cpt1973145802","article-title":"Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital","volume":"14","author":"Schroder, H.; Lewkonia, R.M.; Price Evans, D.A.","year":"1973","unstructured":"Schroder H, Lewkonia RM, Price Evans DA. Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital. Clin Pharmacol Ther 1973; 14: 802-9.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_22","first-page":"107","article-title":"Absorption and excretion of a single 1 g dose of azodisal sodium in subjects with ileostomy. Scand J7 Gastroenterol","volume":"18","author":"Sandberg-Gertzen, H.; Ryde, M.; Jarnerot, G.","year":"1983","unstructured":"Sandberg-Gertzen H, Ryde M, Jarnerot G. Absorption and excretion of a single 1 g dose of azodisal sodium in subjects with ileostomy. Scand J7 Gastroenterol 1983; 18: 107-11."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF01299921","article-title":"Studies of two novel sulphasalazine analogs, ipsalazide and balsalazide","volume":"28","author":"Chan, R.P.; Pope, D.J.; Gilbert, A.P.; Sacra, P.J.; Baron, J.H.; Lennard-Jones, J.E.","year":"1983","unstructured":"Chan RP, Pope DJ, Gilbert AP, Sacra PJ, Baron JH, Lennard-Jones JE. Studies of two novel sulphasalazine analogs, ipsalazide and balsalazide. Dig Dis Sci 1983; 28: 609-15.","journal-title":"Dig Dis Sci"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/00365529209000155","article-title":"Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea","volume":"27","author":"Rijk, M.C.M.; van Schaik, A.; van Tongeren, J.H.M.","year":"1992","unstructured":"Rijk MCM, van Schaik A, van Tongeren JHM. Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea. Scand J Gastroenterol 1992; 27: 863-8.","journal-title":"Scand J Gastroenterol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/gut.31.11.1271","article-title":"Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: Comparison of intraluminal colonic concentrations, serum values, and urinary excretion","volume":"31","author":"L, Staerk Laursen; M, Stokholm; K, Bukhave; J, Rask-Madsen; K, Lauritsen","year":"1990","unstructured":"Staerk Laursen L, Stokholm M, Bukhave K, Rask-Madsen J, Lauritsen K. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: Comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut 1990; 31: 1271-6.","journal-title":"Gut"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/bmj.2.5805.104","article-title":"pH profile of gut as measured by radiotelemetry capsule","volume":"2","author":"Meldrum, S.J.; Watson, B.W.; Riddle, H.C.; Bown, R.L.; Sladen, G.E.","year":"1972","unstructured":"Meldrum SJ, Watson BW, Riddle HC, Bown RL, Sladen GE. pH profile of gut as measured by radiotelemetry capsule. BMJ 1972; 2: 104-6.","journal-title":"BMJ"},{"key":"ref_27","first-page":"1062","article-title":"5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and","volume-title":"excretion in humans. Gastroenterology 1982; 83","author":"Rasmussen, S.N.; Bondesen, S.; Hvidberg, E.F.","unstructured":"Rasmussen SN, Bondesen S, Hvidberg EF, et al. 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans. Gastroenterology 1982; 83: 1062-70."},{"key":"ref_28","first-page":"107","article-title":"Disposition of 5-aminosalicylic acid and acetyl -5-aminosalicylic acid after oral and rectal administration in healthy subjects","volume-title":"5-aminosalicylic acid compounds. Pharmacokinetic and clinical aspects","author":"van Hogenzand RA; van Hees PAM; van Tongeren JHM","year":"1986","unstructured":"van Hogenzand RA, van Hees PAM, van Tongeren JHM. Disposition of 5-aminosalicylic acid and acetyl -5-aminosalicylic acid after oral and rectal administration in healthy subjects. In: van Hogenzand RA ed. 5-aminosalicylic acid compounds. Pharmacokinetic and clinical aspects. (Thesis) University of Nijwegen 1986: 107-17."},{"issue":"148","key":"ref_29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/00365528809101542","article-title":"Clinical tolerance of olsalazine","volume":"23","author":"Jarnerot, G.","year":"1988","unstructured":"Jarnerot G. Clinical tolerance of olsalazine. Scand J Gastroenterol 1988; 23 (Suppl 148): 21-3.","journal-title":"Scand J Gastroenterol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2036.1992.tb00544.x","article-title":"Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine","volume":"6","author":"Giaffer, M.H.; O'Brien, C.J.; Holdsworth, C.D.","year":"1992","unstructured":"Giaffer MH, O'Brien CJ, Holdsworth CD. Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine. Alimentary Pharmacology and Therapy 1992; 6: 51-9.","journal-title":"Alimentary Pharmacology and Therapy"},{"article-title":"Committee on Safety of Medicines. Nephrotoxicity associated with Mesalazine. Current problems no 30","year":"1990","key":"ref_31","unstructured":"Committee on Safety of Medicines. Nephrotoxicity associated with Mesalazine. Current problems no 30. London: Committee on Safety of Medicines, December 1990."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/bmj.1.5793.152","article-title":"Nephrotoxic lesions from 5-aminosalicylic acid","volume":"1","author":"Calder, J.C.; Funder, C.C.; Green, C.R.; Ham, K.N.; Tange, J.D.","year":"1972","unstructured":"Calder JC, Funder CC, Green CR, Ham KN, Tange JD. Nephrotoxic lesions from 5-aminosalicylic acid. BMJ 1972; 1: 152-4.","journal-title":"BMJ"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gut.33.7.1006","article-title":"Sulphasalazine induced renal failure","volume":"33","author":"Dwarakanath, A.D.; Michael, J.; Allan, R.N.","year":"1992","unstructured":"Dwarakanath AD, Michael J, Allan RN. Sulphasalazine induced renal failure. Gut 1992; 33: 1006-7.","journal-title":"Gut"},{"key":"ref_34","first-page":"146","article-title":"Gastric emptying of indigestible tablets in relation to compositions and time of ingestion of meals studied by metal detector","volume":"36","author":"Ewe, K.; Press, A.G.; Bollen, S.; Schuku, I.","year":"1992","unstructured":"Ewe K, Press AG, Bollen S, Schuku I. Gastric emptying of indigestible tablets in relation to compositions and time of ingestion of meals studied by metal detector. Dig Dis Sci 1992; 36: 146-52.","journal-title":"Dig Dis Sci"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.35.9.1155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:31:31Z","timestamp":1757280691000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.35.9.1155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[1994,9,1]]},"published-print":{"date-parts":[[1994,9]]}},"alternative-id":["10.1136\/gut.35.9.1155"],"URL":"https:\/\/doi.org\/10.1136\/gut.35.9.1155","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"type":"print","value":"0017-5749"},{"type":"electronic","value":"1468-3288"}],"subject":[],"published":{"date-parts":[[1994,9]]}}}